🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

Excess Spread — Buy the right portfolios, health, wealth and happiness, the 99%

Share

Market Wrap

Excess Spread — Buy the right portfolios, health, wealth and happiness, the 99%

Owen Sanderson's avatar
  1. Owen Sanderson
11 min read

Buying the right stuff

Barclays has been enthusiastically selling assets over the past couple of years — most prominently the Peninsula portfolio (Barclays Italy). GoldenTree has won the larger performing portion, a big splash for Matt Jones after a year at the US hedge fund (good to see a non-Pimco entity in the lead), while SPF has won the NPLs.

But to Peninsula you could add Gemgarto 2023-1, which deconsolidated some of the higher LTV Kensington lending, Pavillion Point of Sale 2021-1, which sold some unsecured consumer lending to Elliott Advisors, Pavillion Mortgages 2021-1 and 2022-1, and the recent sale of US credit cards to Blackstone.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks